Current Report Filing (8-k)
10 January 2023 - 08:09AM
Edgar (US Regulatory)
Core Scientific, Inc./tx 0001839341 false
NONE NONE 0001839341 2023-01-09 2023-01-09 0001839341
us-gaap:CommonStockMember 2023-01-09 2023-01-09 0001839341
us-gaap:WarrantMember 2023-01-09 2023-01-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9,
2023
Core
Scientific, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
Delaware |
|
001-40046 |
|
86-1243837 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
210 Barton Springs Road |
|
|
|
Suite 300 |
|
|
|
Austin, Texas |
|
78704 |
|
(Address of principal executive
offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (512)
402-5233
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant
under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
Common stock, par value $0.0001 per share |
|
CORZQ |
|
*
|
|
Warrants, exercisable for shares of common stock |
|
CORZWQ |
|
*
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this
chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
| * |
The registrant’s common stock and warrants began trading
exclusively on the
OTC Pink Marketplace on January 3, 2023 under
the Symbols “CORZQ” and “CRZWQ,” respectively.
|
| Item 7.01. |
Regulation FD Disclosure.
|
On January 9, 2023, the Company issued a press release
announcing certain production and operations updates for the months
of November and December 2022. A copy of the press release is
attached hereto as Exhibit 99.1 and is incorporated into this Item
7.01 by reference.
The information in Item 7.01 of this Current Report on Form
8-K, including Exhibit
99.1, is furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended,
nor shall it be deemed incorporated by reference in any filing made
by the Company under the Securities Act of 1933, as amended,
whether made before or after the date hereof, regardless of any
general incorporation language in such filing.
| Item 9.01 |
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Core Scientific, Inc. |
|
|
|
| Dated: January 9,
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Todd M. DuChene
|
|
|
|
|
Name: |
|
Todd M. DuChene |
|
|
|
|
Title: |
|
President and Chief Legal
Officer |
Core Scientific (NASDAQ:CORZ)
Historical Stock Chart
From Mar 2023 to Mar 2023
Core Scientific (NASDAQ:CORZ)
Historical Stock Chart
From Mar 2022 to Mar 2023
